The Clinicogenetic Risk Model m7-FLIPI. Reprinted from Lancet Oncology, Vol 16/edition 9, Pastore A et al, Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, 1111-1122, Copyright 2015, with permission from Elsevier.